News-Medical.Net on MSN
Integrating AI into colon cancer diagnosis improves the speed and accuracy of detection
A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...
Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...
A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...
CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based ...
Dealbreaker on MSN
Liquid biopsy firm Freenome finds a way to the public markets via $330M SPAC merger
Freenome’s SPAC merger agreement comes as the liquid biopsy developer prepares for potential 2026 commercialization of ...
News-Medical.Net on MSN
Machine learning tool identifies compounds that induce cancer cells into senescence
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled "SAMP ...
DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...
The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback